Number of shares outstanding for Lineage Cell Therapeutics (LCTX)

Number of shares outstanding as of November 2024 : 188,813,000

According to Lineage Cell Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 188,813,000. At the end of 2024 the company had 188,813,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Lineage Cell Therapeutics from 1997 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	0.18 B	7.97%
2023	0.17 B	2.99%
2022	0.16 B	1.29%
2021	0.16 B	11.77%
2020	0.14 B	0.12%
2019	0.14 B	17.96%
2018	0.12 B	10.15%
2017	0.11 B	12.18%
2016	0.10 B	29.73%
2015	79.22 M	1.62%
2014	77.95 M	40.16%
2013	55.62 M	12.91%
2012	49.26 M	0.75%
2011	48.89 M	14.64%
2010	42.65 M	36.34%
2009	31.28 M	31.78%
2008	23.73 M	3.96%
2007	22.83 M	1.15%
2006	22.57 M	26.32%
2005	17.87 M	0.34%
2004	17.81 M	30.44%
2003	13.65 M	11.11%
2002	12.28 M	6.25%
2001	11.56 M	5.98%
2000	10.91 M	-0.35%
1999	10.95 M	9.52%
1998	10 M	0%
1997	10 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
ORIC Pharmaceuticals ORIC	70,348,414	-62.74%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions